← Back
$SPRY All transactions

ARS Pharmaceuticals, Inc.

M

$ Value

$0

Shares

50,000

Price

$0

Filed

May 22

Insider

Name

Scott Kathleen D.

Title

Chief Financial Officer

CIK

0001794284

Roles

Officer

Transaction Details

Transaction Date

2025-05-20

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

752,330

Footnotes

Includes 2,475 shares acquired under the Issuer's 2020 Employee Stock Purchase Plan on December 31, 2024. | The weighted average sale price for the transaction reported was $14.1033 and the range of prices were between $14.10 and $14.115. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided. | Immediately exercisable.

Filing Info

Accession No.

0001415889-25-014184

Form Type

4

Issuer CIK

0001671858

Scott Kathleen D.'s History

Date Ticker Type Value
2025-08-21 SPRY M $19K
2025-08-21 SPRY $188K
2025-08-21 SPRY M $0
2025-05-20 SPRY M $75K
2025-05-20 SPRY $705K
2025-05-20 SPRY M $0

Other Insiders at SPRY (90d)

No other insider activity at this issuer in the last 90 days.